PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.18%
Negative revenue growth while QCOM stands at 3.09%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-54.96%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
23.89%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
23.89%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
5.19%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.97%
Share reduction more than 1.5x QCOM's 19.06%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.97%
Diluted share reduction more than 1.5x QCOM's 19.06%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-10.10%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-70.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-120.49%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
36.26%
10Y revenue/share CAGR under 50% of QCOM's 143.66%. Michael Burry would suspect a lasting competitive disadvantage.
10.62%
5Y revenue/share CAGR under 50% of QCOM's 143.66%. Michael Burry would suspect a significant competitive gap or product weakness.
9.60%
3Y revenue/share CAGR under 50% of QCOM's 143.66%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.27%
3Y OCF/share CAGR of 22.27% while QCOM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
616.08%
10Y net income/share CAGR of 616.08% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-18.38%
Negative 5Y net income/share CAGR while QCOM is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
456.75%
3Y net income/share CAGR of 456.75% while QCOM is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.07%
Negative 3Y equity/share growth while QCOM is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
33.94%
Dividend/share CAGR of 33.94% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-18.09%
Negative near-term dividend growth while QCOM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.28%
AR growth is negative/stable vs. QCOM's 17.00%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.50%
Inventory shrinking or stable vs. QCOM's 16.92%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
7.75%
Asset growth above 1.5x QCOM's 2.12%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.80%
Positive BV/share change while QCOM is negative. John Neff sees a clear edge over a competitor losing equity.
-2.91%
We’re deleveraging while QCOM stands at 0.99%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
0.30%
SG&A growth of 0.30% while QCOM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.